Ticker Details
Jazz Pharmaceuticals plc Jazz Pharmaceuticals PLC is a biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
IPO Date:	June 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.63 | 2.15%
Avg Daily Range (30 D):	$3.86 | 1.53%
Avg Daily Range (90 D):	$4.40 | 1.84%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	.79M
Avg Daily Volume (90 D):	.71M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	42

Institutional Trades
Total Institutional Trades:	11,192
Avg Institutional Trade:	$5.24M
Avg Institutional Trade (30 D):	$12.84M
Avg Institutional Trade (90 D):	$12.96M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$9.04M
Avg Closing Trade (30 D):	$28.57M
Avg Closing Trade (90 D):	$32.05M
Avg Closing Volume:	65.35K

News

Sep 2, 2026 @ 3:30 PM Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings R... Source: Na

Sep 1, 2026 @ 4:05 PM Axsome Begins Phase III Study on AXS-05 for Smokin... Source: Na

Sep 1, 2026 @ 4:02 PM JAZZ Rises on Updated OS Results From Gastric Canc... Source: Na

May 13, 2026 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Apr 20, 2026 @ 5:00 PM Pheochromocytoma and Paraganglioma Market to Exhib... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$3.05	$4.73
Diluted EPS		$2.78	$4.43
Revenue		$1.21B	$1.07B
Gross Profit
Net Income / Loss		$192.8M	$293.1M
Operating Income / Loss		$248.2M	$336.6M
Cost of Revenue
Net Cash Flow		$-224.5M	$452.4M
PE Ratio